Dalia Moawad

Head, Scientific Strategy, US Medical Affairs at Genentech

Dalia Moawad, MD has a diverse and extensive background in medical affairs, clinical research, and health informatics. With experience in various pharmaceutical companies such as Genentech, Five Prime Therapeutics, Bristol-Myers Squibb, and Affymax, Dalia has held leadership roles in neuro rare diseases, influenza, and established products. Dalia has also been involved in clinical trials and projects related to hepatitis, liver transplant, and telemedicine. With a strong educational foundation in medicine and surgery from Ain Shams University, Dalia brings a wealth of expertise to their work in the medical field.

Links

Org chart

Timeline

  • Head, Scientific Strategy, US Medical Affairs

    April, 2023 - present

  • Head, Neuro Rare Diseases, US Med Affairs

    March, 2020

  • Group Medical Director, US Medical Affairs

    February, 2020

  • Associate Group Med Director, US Medical Affairs

    March, 2019

  • Principal Medical Director/medical Lead, US Medical Affairs

    July, 2018

  • Senior Medical Director/medical Lead, US Medical Affairs

    July, 2014

  • Associate Medical Director, Medical Affairs

    March, 2010

  • Assistant Medical Director, Clinical Development

    August, 2008

  • Clinical Scientist, Clinical Development

    April, 2007

  • Clinical Trial Lead, Clinical Development

    September, 2006

View in org chart